CROSS CTRY HEALTHCARE INC's ticker is CCRN and the CUSIP is 227483104. A total of 126 filers reported holding CROSS CTRY HEALTHCARE INC in Q4 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $708,573 | -16.0% | 28,583 | -4.9% | 0.01% | -12.5% |
| Q2 2023 | $844,001 | +19.0% | 30,057 | -5.4% | 0.01% | +14.3% |
| Q1 2023 | $709,196 | +111937.3% | 31,774 | +33.4% | 0.01% | -30.0% |
| Q4 2022 | $633 | -99.9% | 23,819 | -8.8% | 0.01% | -16.7% |
| Q3 2022 | $741,000 | +38.5% | 26,124 | +1.7% | 0.01% | +33.3% |
| Q2 2022 | $535,000 | -1.5% | 25,687 | +2.5% | 0.01% | +28.6% |
| Q1 2022 | $543,000 | -23.2% | 25,057 | -1.7% | 0.01% | -22.2% |
| Q4 2021 | $707,000 | +27.4% | 25,482 | -2.5% | 0.01% | +28.6% |
| Q3 2021 | $555,000 | +28.8% | 26,145 | +0.1% | 0.01% | +40.0% |
| Q2 2021 | $431,000 | +32.2% | 26,107 | +0.2% | 0.01% | +25.0% |
| Q1 2021 | $326,000 | +30.9% | 26,064 | -7.1% | 0.00% | +33.3% |
| Q4 2020 | $249,000 | +17.5% | 28,050 | -14.0% | 0.00% | 0.0% |
| Q3 2020 | $212,000 | +16.5% | 32,633 | +10.3% | 0.00% | 0.0% |
| Q2 2020 | $182,000 | -13.7% | 29,597 | -5.6% | 0.00% | -25.0% |
| Q1 2020 | $211,000 | -28.0% | 31,349 | +24.3% | 0.00% | 0.0% |
| Q4 2019 | $293,000 | +13.1% | 25,224 | +0.5% | 0.00% | 0.0% |
| Q3 2019 | $259,000 | +10.7% | 25,109 | +0.5% | 0.00% | 0.0% |
| Q2 2019 | $234,000 | +35.3% | 24,993 | +1.9% | 0.00% | +33.3% |
| Q1 2019 | $173,000 | -0.6% | 24,538 | +3.4% | 0.00% | 0.0% |
| Q4 2018 | $174,000 | -12.6% | 23,722 | +3.9% | 0.00% | 0.0% |
| Q3 2018 | $199,000 | -24.6% | 22,837 | -2.8% | 0.00% | -25.0% |
| Q2 2018 | $264,000 | -1.5% | 23,492 | -2.6% | 0.00% | 0.0% |
| Q1 2018 | $268,000 | -14.9% | 24,119 | -2.2% | 0.00% | 0.0% |
| Q4 2017 | $315,000 | -16.9% | 24,660 | -7.4% | 0.00% | -20.0% |
| Q3 2017 | $379,000 | +26.8% | 26,642 | +15.1% | 0.01% | +25.0% |
| Q2 2017 | $299,000 | -12.8% | 23,143 | -3.1% | 0.00% | 0.0% |
| Q1 2017 | $343,000 | -8.8% | 23,882 | -0.8% | 0.00% | -20.0% |
| Q4 2016 | $376,000 | +27.0% | 24,076 | -4.2% | 0.01% | +25.0% |
| Q3 2016 | $296,000 | -15.2% | 25,128 | +0.3% | 0.00% | -20.0% |
| Q2 2016 | $349,000 | +15.2% | 25,053 | -3.8% | 0.01% | +25.0% |
| Q1 2016 | $303,000 | -31.3% | 26,056 | -3.2% | 0.00% | -20.0% |
| Q4 2015 | $441,000 | +21.5% | 26,929 | +1.0% | 0.01% | 0.0% |
| Q3 2015 | $363,000 | +11.3% | 26,651 | +3.6% | 0.01% | +25.0% |
| Q2 2015 | $326,000 | +1.6% | 25,723 | -4.8% | 0.00% | 0.0% |
| Q1 2015 | $321,000 | -2.7% | 27,034 | +2.2% | 0.00% | 0.0% |
| Q4 2014 | $330,000 | +33.6% | 26,449 | -0.7% | 0.00% | +33.3% |
| Q3 2014 | $247,000 | +38.8% | 26,633 | -2.7% | 0.00% | +50.0% |
| Q2 2014 | $178,000 | -19.1% | 27,363 | +0.2% | 0.00% | 0.0% |
| Q1 2014 | $220,000 | -22.5% | 27,298 | -4.1% | 0.00% | -33.3% |
| Q4 2013 | $284,000 | +63.2% | 28,454 | -0.6% | 0.00% | +50.0% |
| Q3 2013 | $174,000 | -2.8% | 28,637 | -17.4% | 0.00% | 0.0% |
| Q2 2013 | $179,000 | -3.2% | 34,651 | -0.3% | 0.00% | 0.0% |
| Q1 2013 | $185,000 | – | 34,758 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Divisadero Street Capital Management, LP | 382,880 | $10,629,000 | 8.88% |
| Zebra Capital Management LLC | 48,488 | $1,346,000 | 2.15% |
| SYSTEMATIC FINANCIAL MANAGEMENT LP | 2,040,078 | $56,633,000 | 1.68% |
| Aristotle Capital Boston, LLC | 1,609,371 | $44,676,000 | 1.05% |
| INVESTMENT MANAGEMENT OF VIRGINIA LLC | 229,880 | $6,381,000 | 1.03% |
| Alpha DNA Investment Management LLC | 54,580 | $1,514,000 | 0.96% |
| GLOBEFLEX CAPITAL L P | 291,400 | $8,090,000 | 0.83% |
| Silverleafe Capital Partners, LLC | 82,367 | $2,287,000 | 0.82% |
| SummerHaven Investment Management, LLC | 53,124 | $1,475,000 | 0.80% |
| HEARTLAND ADVISORS INC | 461,555 | $12,813,000 | 0.75% |